Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy
Continuous high doses of radiation can cause irreversible side effects and radiation resistance; thus, advanced radiosensitizers are urgently needed. To overcome this problem, we developed a nano platelet radiosensitization system (PCA) by coating the chemotherapeutic drug cisplatin (CDDP) loaded go...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9fb4a9b552f34f1ead41e0f8fc7af4fe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9fb4a9b552f34f1ead41e0f8fc7af4fe |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9fb4a9b552f34f1ead41e0f8fc7af4fe2021-11-30T17:49:28ZPlatelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy2234-943X10.3389/fonc.2021.793006https://doaj.org/article/9fb4a9b552f34f1ead41e0f8fc7af4fe2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.793006/fullhttps://doaj.org/toc/2234-943XContinuous high doses of radiation can cause irreversible side effects and radiation resistance; thus, advanced radiosensitizers are urgently needed. To overcome this problem, we developed a nano platelet radiosensitization system (PCA) by coating the chemotherapeutic drug cisplatin (CDDP) loaded gold nanocages (AuNs) within the platelet membrane. The developed PCA system may enable AuNs to have immune escape and targeting capabilities. After administration, PCA will actively target tumor cells and avoid being cleared by the immune system. Subsequently, CDDP, which destroys tumor cell DNA, can not only kill tumor cells directly but also combine with AuNs, which deposit radiation energy into tumor tissues, reducing RT resistance. In vivo and in vitro studies revealed that the combination of PCA with RT (2Gy) efficiently inhibits tumor proliferation without causing side effects such as inflammation. To conclude, this is the first attempt to use platelet membranes to correctly transport AuNs while also accomplishing low-dose RT, which could help AuNs-based tumor RT become more effective.Mingzhu ChenPing WangDazhen JiangZhirong BaoHong QuanFrontiers Media S.A.articleplatelet membranesgold nanocagesdrug deliverylow-dose radiotherapycisplatinNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
platelet membranes gold nanocages drug delivery low-dose radiotherapy cisplatin Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
platelet membranes gold nanocages drug delivery low-dose radiotherapy cisplatin Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Mingzhu Chen Ping Wang Dazhen Jiang Zhirong Bao Hong Quan Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy |
description |
Continuous high doses of radiation can cause irreversible side effects and radiation resistance; thus, advanced radiosensitizers are urgently needed. To overcome this problem, we developed a nano platelet radiosensitization system (PCA) by coating the chemotherapeutic drug cisplatin (CDDP) loaded gold nanocages (AuNs) within the platelet membrane. The developed PCA system may enable AuNs to have immune escape and targeting capabilities. After administration, PCA will actively target tumor cells and avoid being cleared by the immune system. Subsequently, CDDP, which destroys tumor cell DNA, can not only kill tumor cells directly but also combine with AuNs, which deposit radiation energy into tumor tissues, reducing RT resistance. In vivo and in vitro studies revealed that the combination of PCA with RT (2Gy) efficiently inhibits tumor proliferation without causing side effects such as inflammation. To conclude, this is the first attempt to use platelet membranes to correctly transport AuNs while also accomplishing low-dose RT, which could help AuNs-based tumor RT become more effective. |
format |
article |
author |
Mingzhu Chen Ping Wang Dazhen Jiang Zhirong Bao Hong Quan |
author_facet |
Mingzhu Chen Ping Wang Dazhen Jiang Zhirong Bao Hong Quan |
author_sort |
Mingzhu Chen |
title |
Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy |
title_short |
Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy |
title_full |
Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy |
title_fullStr |
Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy |
title_full_unstemmed |
Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy |
title_sort |
platelet membranes coated gold nanocages for tumor targeted drug delivery and amplificated low-dose radiotherapy |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/9fb4a9b552f34f1ead41e0f8fc7af4fe |
work_keys_str_mv |
AT mingzhuchen plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy AT pingwang plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy AT dazhenjiang plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy AT zhirongbao plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy AT hongquan plateletmembranescoatedgoldnanocagesfortumortargeteddrugdeliveryandamplificatedlowdoseradiotherapy |
_version_ |
1718406397863919616 |